§ 13F · FUND PROFILE
Fairmount Funds Management LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 12Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$226M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | DMRA | DAMORA THERAPEUTICS INC | 8.71M | $226M | 16.3% | NEW |
| 2 | DNTH | DIANTHUS THERAPEUTICS INC | 2.54M | $213M | 15.4% | +19% |
| 3 | COGT | COGENT BIOSCIENCES INC | 5.50M | $212M | 15.3% | −39% |
| 4 | SYRE | SPYRE THERAPEUTICS INC | 4.02M | $203M | 14.6% | ±0% |
| 5 | ORKA | ORUKA THERAPEUTICS INC | 3.71M | $182M | 13.1% | ±0% |
| 6 | VRDN | VIRIDIAN THERAPEUTICS INC | 3.91M | $77M | 5.5% | ±0% |
| 7 | ELVN | ENLIVEN THERAPEUTICS INC | 1.86M | $73M | 5.3% | −50% |
| 8 | JBIO | JADE BIOSCIENCES INC | 4.55M | $64M | 4.6% | ±0% |
| 9 | CBIO | CRESCENT BIOPHARMA INC. | 2.75M | $50M | 3.6% | ±0% |
| 10 | ZBIO | ZENAS BIOPHARMA INC | 2.36M | $46M | 3.3% | +7% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE FAIRMOUNT SIGNAL
AC read
Fairmount Funds Management LLC is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed